This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Are Investors Undervaluing Acadia Healthcare (ACHC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Earnings Preview: Acadia Healthcare (ACHC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Lies Ahead for Centene (CNC) Stock in Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter earnings are likely to gain traction from growth in revenues and membership strength, partly offset by high operating costs.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 earnings surge on the back of operating performance and strong growth across all core businesses.
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
Implied Volatility Surging for Acadia Healthcare (ACHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
New Strong Sell Stocks for December 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for December 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Acadia Healthcare Down for Second Year, What Awaits in 2019?
by Zacks Equity Research
Shares of Acadia Healthcare (ACHC) seem to have no respite from its high debt and profitability concern in U.K. business.
Moody's Downgrades Acadia's (ACHC) Outlook, Affirms Ratings
by Zacks Equity Research
Acadia Healthcare (ACHC) receives rating actions from Moody's. Outlook down to negative from stable.
Acadia Healthcare (ACHC) Down 15.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Get Rid of Acadia Healthcare (ACHC) Now?
by Zacks Equity Research
Acadia Healthcare (ACHC) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Moving Average Crossover Alert: Acadia Healthcare
by Zacks Equity Research
Acadia Healthcare Company, Inc. (ACHC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Implied Volatility Surging for Acadia Healthcare (ACHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
Acadia Healthcare (ACHC) Misses on Q3 Earnings, Trims View
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 earnings missed estimates and declined year over year on increase in expenses.
Acadia Healthcare (ACHC) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of -15.38% and -0.29%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Q3 Earnings Due on Nov 5: ACHC, THC, BKD, TVTY
by Zacks Equity Research
Players in the healthcare industry should gain from an increase in revenues, partly offset by a rise in operating costs.
Acadia Healthcare (ACHC) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Healthcare (ACHC) Q3 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Healthcare (ACHC) Surges: Stock Moves 7.9% Higher
by Zacks Equity Research
Acadia Healthcare (ACHC) shares rose nearly 8% in the last trading session, amid huge volumes.
Is Acadia Healthcare Company (ACHC) a Great Stock for Value Investors?
by Zacks Equity Research
Is Acadia Healthcare Company (ACHC) a great pick from the value investor's perspective right now? Read on to know more.
Why Is Acadia Healthcare (ACHC) Up 2.6% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare to Benefit from Growing Behavioral Issues
by Zacks Equity Research
Acadia Healthcare (ACHC) is well placed to serve patients with increasing incidence of behavioral and mental health illness.
Acadia Healthcare (ACHC) Posts In-Line Q2 Earnings, Cuts View
by Zacks Equity Research
Acadia Healthcare (ACHC)'s second-quarter earnings grow on the back of extra beds procured by units facilities. However, the company trims its full-year view.